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Abstract: Although 1,25-dihydroxyvitamin D [1,25(OH)2D] is the biologically active form of vitamin D, measurement of 
the total serum 25-hydroxyvitamin D [25(OH)D] level is the gold standard used to define vitamin D status. Currently, it is 
widely accepted that serum 25 (OH) D levels below 20 ng/ml defines vitamin D deficiency. According to this definition, 
there appears to be pandemic vitamin D deficiency in the Black population. However, there is no evidence of higher-than-
normal rates of common complications and symptomology of true vitamin D deficiency in the Black population. What is 
going on? We researched the MEDLINE databases to find studies, from 1967 to present, that directly compare between 
Blacks and Caucasians the following: serum vitamin D level, serum calcium level, serum parathyroid hormone level, bone 
mineral density and health, and non-skeletal risks associated with vitamin D deficiency. The available studies consistently 
show that Blacks tend to have serum 25(OH)D levels in the deficient range while their serum 1,25(OH)2D level is similar 
to, if not even slightly higher than that of Caucasians, and that the serum Ca2+ level in Blacks is virtually identical to that 
in Caucasians. Therefore, it appears that the serum 25(OH)D level is not the best marker of vitamin D sufficiency or 
deficiency in Blacks. In the future, clinical evaluation of the vitamin D status in the Black population needs to consider 
other serum biomarkers such as 1,25(OH)2D and/or bioavailable 25(OH)D.  
Keywords: Black, deficiency, health, vitamin D. 
INTRODUCTION 
 There are two sources of vitamin D for the human body: 
diet and biosynthesis of vitamin D in the skin upon exposure 
to adequate UV-B rays. As illustrated in Fig. (1), irradiation 
of the epidermis of the skin by UV-B rays induces a non-
enzymatic reaction that converts 7-dehydrocholesterol to 
previtamin D. The previtamin D then undergoes a slow, 
spontaneous conversion to vitamin D3. Vitamin D3 is 
transported out of the skin and undergoes two rounds of 
hydroxylation reactions; the first in the liver and the second 
in kidney. In the liver, vitamin D3 is converted to 25(OH)D3 
by the enzyme, 25-hydroxlylase. In the kidney, the 
25(OH)D3 is converted to the biologically active 
1,25(OH)2D3 by the enzyme, 25-hydroxycalciferol 1-α-
hydroxylase (1-α-hydroxylase) in the proximal convoluted 
tubule [1]. Dietary sources contain vitamin D3 and vitamin 
D2. Metabolism of vitamin D2 in the human body is the same 
as that of vitamin D3. In general, hydroxylated metabolites of 
vitamin D2 and vitamin D3 are simply referred to as 
25(OH)D and 1,25(OH)2D. It should be noted that  
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1,25(OH)2D is the biologically active vitamin D and that the 
biological effect of 1,25(OH)2D on cells is mediated by the 
vitamin D receptor (VDR), a specific ligand-dependent 
nuclear transcription factor that regulates expression of a 
large number of genes in many organs including bone, 
muscle, pancreas, brain, the pituitary, and the immune 
system [2, 3].  
 The melanin pigment is an excellent natural absorbent of 
the UV-B radiation, and therefore dark-skinned people 
require substantially more exposure to UV-B rays than fair 
skinned people in order to synthesize an adequate amount of 
vitamin D3 [4, 5].
 
Thus, dark-skinned people, such as Blacks 
and dark skinned Indians, are more susceptible to developing 
vitamin D deficiency in the absence of adequate sunlight 
exposure or without taking vitamin D supplements [4-7].
 
The 
significance of adequate sunlight exposure for the vitamin D 
status in dark-skinned people is best illustrated by a recent 
finding showing that those Africans, such as the Maasai and 
Hadzabe people, who still maintain a hunter-gather life style 
and get plenty of sunlight exposure, have a serum level range 
of 25(OH)D at 43 ng/mL to 59 ng/mL [8], a concentration 
range that can only be found in sunlight-replete Caucasians 
lifeguards in the summer [9]. 
 The conversion of 25(OH)D to 1,25(OH)2D by the 1--
hydroxylase in the kidney is strictly regulated (Fig. 1). The 
activity of 1--hydroxylase is stimulated primarily by 
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parathyroid hormone (PTH) and inhibited by phosphate, 
Ca
2+
, and fibroblast growth factor 23 (FGF23). In addition, 
1--hydroxylase is subjected to feedback inhibitory 
regulation by 1,25(OH)2D. At high concentrations, 
1,25(OH)2D induces inhibition of its own synthesis by down-
regulating 1--hydroxylase activity in the kidney and 
activating vitamin D 24 hydroxylase in peripheral tissues 
(Fig. 1). The 24-hydroxylase hydroxylates both 25(OH)D 
and 1,25(OH)2D on the #24-carbon to yield biologically 
inactive 24-hydroxyl derivatives, 24,25-dihydroxy-vitamin D 
[24,25(OH)2D] and 1,24,25-trihydroxyvitamin D [1,24,25 
(OH)3D] [11, 12]. The combined actions of PTH, FGF23, 
1,25(OH)2D, Ca
2+
 and phosphate on the vitamin D metabolic 
enzymes lead to homeostasis of 1,25(OH)2D, which is 
important for the maintenance of calcium and phosphate 
homeostasis in the blood. 
 The classical function of vitamin D is to regulate calcium 
and phosphorus homeostasis in the blood, which is critical 
for bone health. Thus, clinical determination of vitamin D 
status is largely based on the relationship between serum 
25(OH)D level and bone disorders [13]. However, 
epidemiological studies have linked vitamin D deficiency 
with a plethora of negative health outcomes, including 
cardiovascular diseases, immune dysfunction, cancer, 
reproductive disorders, neurological disorders, and metabolic 
syndromes [13-16]. The action mechanism of the 
biologically active vitamin D, 1,25(OH)2D, involves nuclear 
vitamin D receptor (VDR) which is ubiquitously expressed 
and acts as ligand-dependent transcription factor that 
regulates the promoters of vitamin D target genes via 
binding to the vitamin D responsive element (VDRE) in the 
promoters of these genes [17].
 
Most cell types in the human 
body appear to respond to 1,25(OH)2D stimulation, and a 
large number of the genes in the human genome are 
regulated by 1,25(OH)2D [2, 3]. In this context, it is 
frightening to see that up to 82.1% Blacks in the US are 
considered to be vitamin D deficient as defined by less than 
20 ng/mL 25(OH)D in the serum [18].
 
Fortunately, there is 
no evidence of high rates of medical complications and 
symptomology of true vitamin D deficiency in the US Black 
population. What is going on? To understand it, we 
researched the MEDLINE databases to find studies, from 
1967 to present, that directly compare between Blacks and 
Caucasians the following: serum vitamin D level, serum 
calcium level, serum parathyroid hormone level, bone 
mineral density and health, and non-skeletal risks associated 
with vitamin D deficiency. To our knowledge, this is the first 
attempt to systematically review the biomedical literature 
concerning specifically the vitamin D status in Blacks. In 
this review, we report on the available information and 
suggest that this pandemic vitamin D deficiency in the black 
population is a false alarm, because most Blacks of both 
genders and at all age groups have healthy serum levels of 
the biologically active 1,25(OH)2D and they are functionally 
vitamin D sufficient despite the fact that their serum 
25(OH)D levels are in the deficient range.  
REVIEW OF EVIDENCE 
Blacks Are Deficient in 25(OH)D but Replete with 
1,25(OH)2D  
 In the blood circulation, up to 90% of 25(OH)D is bound 
to vitamin D-binding proteins (VDBP), the rest is mostly 
bound to albumin, and less than 1% remains free [10]. The 
25(OH)D circulates in the blood at ng/mL concentrations 
 
 
Fig. (1). Metabolism of vitamin d in human body. 
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and has a half-life of approximately 15 days whereas the 
1,25(OH)2D circulates at pg/mL concentrations and has a 
half-life of approximately 15 hours [19-21].
 
Even though 
1,25(OH)2D is the biologically active form of vitamin D, 
determination of vitamin D status has been all about 
measuring the total serum levels of 25(OH)D for both 
technical convenience and the fact that the serum level of 
25(OH)D is largely proportional to the serum level of 
1,25(OH)2D in the general non-black population. The 
available studies have consistently demonstrated that many 
Blacks of both genders and at all life stages – neonates, 
preadolescents, adolescents, middle ages, and old ages – 
have serum 25(OH)D levels in the ranges of deficiency 
(Table 1). However, studies that have directly compared the 
serum levels of both 25(OH)D and 1,25(OH)2D between 
Blacks and Caucasians consistently found that the serum 
1,25(OH)2D level in Blacks is similar if not even slightly 
higher than that in Caucasians, notwithstanding the 
deficiencies of 25(OH)D (Table 1). These data indicate that 
Blacks are by large replete with the biologically active 
vitamin D and therefore are not functionally vitamin D 
deficient and that low serum 25(OH)D level in Blacks is not 
indicative of vitamin D deficiency. 
Bioavailability of Serum 25(OH)D in Blacks 
 The commonly used assays that determine the 
concentrations of vitamin D in the serum measure total 
circulating 25(OH)D without distinguishing the free vitamin 
D from the vitamin D bound to vitamin D binding protein 
(VDBP) and albumin. Recently, Powe et al. [22] determined 
and compared the amounts of bioavailable 25(OH)D – that 
is, the amount of serum 25(OH)D not bound to VDBP – 
between Blacks and Caucasians and found the following: (i) 
the amount of bioavailable serum 25(OH)D is proportional 
to the total amount of 25(OH)D in Caucasians; (ii) Blacks 
have vitamin D deficiency as defined by the low serum 
25(OH)D level; (iii) Blacks have lower serum VDBP level 
than Caucasians; and (iv) the serum bioavailable 25(OH)D 
level in Blacks is similar to that of Caucasians after adjusting 
the VDBP-bound 25(OH)D. This study explains that one 
reason why Blacks have healthy levels of serum 1,25(OH)2D 
is because they have adequate levels of bioavailable 
25(OH)D in the serum due to decreased serum VDBP level. 
Hence, it appears that although it is not necessary for 
Caucasians, a measurement of the serum 1,25(OH)2D level 
or the amount of the bioavailable 25(OH)D in the serum 
would more accurately determine vitamin D sufficiency or 
deficiency in the Black population. This is very important 
given the fact that these days taking high doses of oral 
vitamin D supplements is the norm of life for people who are 
diagnosed to be vitamin D deficient, and that excessive 
intake of vitamin D has the potential to cause chronic toxic 
effects of hypervitaminosis D, which presents as 
hypercalcemia and renal damage [23-25]. It is not 
unreasonable to think that treatment of the traditionally 
determined “vitamin D deficient” Blacks may cause a severe 
toxicity of hypervitaminosis D. 
PTH Status, Calcium Homeostasis and Bone Health in 
Blacks 
 The classical function of 1,25(OH)2D is its ability to act 
in the intestine to stimulate the absorption of calcium and 
phosphorous, and in the kidney to stimulate the reabsorption 
of calcium and phosphorus. Thus, chronic deficiency of 
1,25(OH)2D in the body due to various reasons, such as loss-
of-function mutations in 1--hydroxylase deficiency and 
hypoparathyroidism, results in bone disorders, such as 
rickets, osteoporosis and osteomalacia. Elevation of the 
blood PTH level is a normal physiological response to 
Table 1. Comparison of the mean blood levels of 25(OH)D, 1,25(OH)2D, PTH, and calcium (Ca
2+) in caucasians and blacks. 
25(OH)D (ng/mL) 1,25(OH)2D (pg/mL) PTH (pg/mL) Serum Ca
2+ (mM) 
Subject Characteristics Reference 
Caucasian Black Caucasian Black Caucasian Black Caucasian Black 
29.9 18.5 N/A N/A 36.6 40.9 N/A N/A Peripubertal females [44] 
27.16 13.1 N/A N/A 35.9 39 N/A N/A Adult females [46] 
31.2 14.8 N/A N/A 38.89 47.08 4.125 2.29 Adult females [48] 
33.2 25.7 36.0 45.4 24.9 28.0 2.38 2.32 Young females [49] 
18.4 10.8 37.31 40.38 23.58 35.83 2.32 2.29 Adult males and females [34] 
25.5 13.8 28.43 28.03 30.27 37.15 1.20 1.21 Adult females [33] 
17.41 11.71 31.45 32.22 N/A N/A N/A N/A Neonates [47] 
32.6 20.4 N/A N/A N/A N/A N/A N/A Adult males 
[22] 
29.3 19.1 N/A N/A N/A N/A N/A N/A Adult females 
36.66 21.15 N/A N/A N/A N/A N/A N/A Adolescent males 
[45] 
39.54 16.23 N/A N/A N/A N/A N/A N/A Adolescent females 
The details of the statistical analysis of the data shown here can be found in the original studies. N/A: not available  
Normal PTH levels: 15-60 pg/ml 
Normal calcium levels: 2.0-2.6 mM 
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decreased calcium level in the blood. The primary functions 
of PTH include stimulation of bone resorption by osteoclasts 
to release calcium from the bone and stimulation of 1--
hydroxylase in the kidney to increase the production of 
1,25(OH)2D, which in turn stimulates intestinal absorption of 
calcium and renal reabsorption of calcium.  
 In comparison to the serum PTH level in Caucasians, the 
serum PTH level in Blacks are approximately 15% higher, a 
common findings in different studies (Table 1). However, 
the serum Ca
2+
 level in Blacks is in the normal range and 
virtually identical to that of Caucasians (Table 1), indicating 
that the elevated serum PTH level in Blacks is not indicative 
of clinical hyperparathtyroidism because hypercalcemia 
normally occurs as a result of hyperparathyroidism [26-28].  
 Although high serum PTH level increases the risk of 
accelerated rate of bone resorption and bone disorders in 
Caucasians, the higher serum PTH level in Blacks actually 
does not seem to cause bone disorders. As a matter of fact, 
Blacks actually have higher bone mass density (BMD), 
higher bone strength and less risk of bone fracture than 
Caucasians as shown in studies conducted by Dawson-
Hughes et al. [29] and Hochberg [30]. For example, the risk 
that a postmenopausal Caucasian woman having a hip 
fracture by age 80 is 11% compared with only 4% for a 
Black woman [31, 32].
 
Apparently, the higher PTH level 
does not cause faster bone turnover in Blacks possibly as a 
result of bone resistance to PTH [33, 34]. This bone 
resistance to PTH is likely to be beneficial to the health of 
the skeletal system in Blacks since it prevents PTH from 
overly stimulating bone resorption when serum PTH level is 
high. Nevertheless, the relationship between serum PTH 
level and vitamin D metabolism seems greatly different 
between Blacks and Caucasians [35]. 
Effect of 1,25(OH)2D on Serum PTH Level in both Blacks 
and Caucasians 
 True vitamin D deficiency can decrease the serum 
calcium level, which in turn can cause secondary 
hyperparathyroidism and increased bone resorption [27]. 
Thus, the increase of serum PTH level is a normal 
compensatory mechanism in response to a decreasing serum 
calcium concentration. But, why do Blacks have elevated 
serum PTH level and yet their serum levels of Ca
2+
 are 
within the normal range? The answer to this question is 
provided by a study involving female Black and Caucasian 
subjects matched with ages and body-mass index. In this 
study, the subjects received 0.25 g 1,25(OH)2D four times a 
day for 2 weeks. At the end of this study, it was found that 
the treatment virtually had no effect on the serum levels of 
25(OH)D and Ca
2+
, it increased the serum 1,25(OH)2D level, 
and it significantly decreased the serum PTH level in all 
subjects (Table 2) [29]. Furthermore, this study 
demonstrated that the treatment caused the average serum 
levels of 1,25(OH)2D in these female Caucasians and Blacks 
to be increased to an almost identical level (40.54 + 3.65 
pg/mL in Caucasians vs 41.73 + 3.85 pg/mL in Blacks), and 
yet the post treatment level of PTH still remained higher in 
Blacks than in Caucasians: the pretreatment PTH levels are 
31.7 + 3.8 pg/mL in Caucasians vs 48.1 + 4.0 pg/mL in 
Blacks and the post treatment PTH levels are 23.4 + 3.6 
pg/mL in Caucasians vs 33.9 + 3.7 pg/mL in Blacks (Table 
2). These findings demonstrated two important points: first, 
these Black women maintain a higher level of serum PTH 
than Caucasian women do even when their serum 
1,25(OH)2D levels are almost identical; second, changes in 
the serum levels of PTH is unrelated to the status of calcium 
and 25(OH)D but directly related to the 1,25(OH)2D level in 
the blood. Since PTH directly affects the production of 
1,25(OH)2D in the kidney by increasing the level of renal 
1α-hydroxylase [36] and since 1,25(OH)2D can directly 
induce suppression of the expression of PTH gene in and 
secretion of PTH from the human parathyroid glands [37], it 
is plausible that there is a Ca
2+
-independent 1,25(OH)2D → 
PTH regulatory loop that regulates the serum 1,25(OH)2D 
level. Thus, PTH would stimulate 1--hydroxylase for 
1,25(OH)2D synthesis and at high concentrations, 
1,25(OH)2D would exert a feedback inhibitory effect on the 
expression of PTH gene in and secretion of PTH from the 
parathyroid glands in a Ca
2+
-independent manner. However, 
there is likely a caveat about this 1,25(OH)2D → PTH loop 
in Blacks – that is, like the bone resistance to PTH [33, 34], 
there could also be kidney resistance to PTH in Blacks. Such 
a kidney desensitization to PTH can explain why the serum 
PTH level in Blacks is higher than that in Caucasians even 
when the 1,25(OH)2D levels are almost identical in both 
groups because higher levels of PTH are needed to maintain 
an adequate level of the 1--hydrolylase in the kidney to 
maintain sufficient amount of 1--hydroxlylase for the 
synthesis of the same amount of 1,25(OH)2D in the bodies of 
Blacks. However, future research involving more subject and 
subjects of both genders and at different age groups is 
needed to investigate this possibility.  
Table 2. Effects of 1,25(OH)2D treatment on the serum levels of 25(OH)D, 1,25(OH)2D, PTH, and calcium (Ca
2+) in adult female 
caucasians and blacks. 
Conditions 25(OH)D (ng/mL) 1,25(OH)2D (pg/mL) PTH (pg/mL) Serum Ca
2+ (mM) Refere
nce Caucasian Blacks Caucasian Blacks Caucasian Blacks Caucasian Blacks 
Before 
treatment 
35.4 (+ 3.7)  19.8(+ 3.9) 30.08 (+ 2.38) 36.81 (+ 2.46) 31.7 (+ 3.8) 48.1 (+4.0) 2.24 (+ 0.02) 2.21 (+ 0.02)  
[29] 
After 
treatment 
38.7 (+ 4.9)  21.7 (+5.2)  40.54 (+ 3.65) 41.73 (+ 3.85)  23.4 (+ 3.6) 33.9 (+3.7) 2.27 (+ 0.02) 2.23 (+ 0.02) 
Normal PTH levels: 15-60 ng/ml 
Normal calcium levels: 2.0-2.6 mM 
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Vitamin D Status and the Risks of Non-skeletal Diseases 
in the Black Population 
 Various epidemiological studies have associated low 
serum 25(OH)D level with negative health outcomes in the 
general population [13-16]. In addition to causing bone 
disorders, vitamin D deficiency is also associated with 
increased risks of developing stroke, coronary heart disease, 
premenstrual syndrome, chronic kidney disease, and systolic 
high blood pressure in Caucasians (Table 3). However, direct 
comparison between Caucasians and Blacks indicate that 
Blacks are relatively protected from the numerous clinical 
complications of the non-skeletal systems (Table 3).  
DISCUSSION 
 In general, vitamin D deficiency is defined as the serum 
level of 25(OH)D lower than 20 ng/mL and closely 
associated with clinical bone disorders, such as rickets, 
osteomalacia and osteoporosis. However, this classification 
of vitamin D deficiency is most unlikely to be applicable to 
Blacks because they have healthy serum levels of the 
biologically active 1,25(OH)2D and calcium at all life stages 
despite the fact that their serum 25(OH)D level is in the 
range of deficiency. Blacks also do not present with high 
rates of the various skeletal and non-skeletal clinical 
complications associated with true vitamin D deficiency 
(Tables 1 and 3). Therefore, the low serum 25(OH)D level 
and normal serum 1,25(OH)2D level in Blacks are indicative 
of functional vitamin D sufficiency. This feature is rather 
unique to Blacks because the serum 25(OH)D level is 
proportional to the serum level of 1,25(OH)2D and 
deficiency of 25(OH)D is indicative of functional vitamin D 
deficiency in people of other races. For instance, the high 
rate of vitamin D deficiency in the Indian population is 
closely associated with high incidences of bone disorders 
[50]. Nevertheless, we believe determination of the vitamin 
D status in Blacks in the future should use test results that 
show the serum levels of bioavailable 25(OH)D and 
1,25(OH)2D. 
 A study by Signorello et al. determined serum 25(OH)D 
level of an African American population in the context of the 
African ancestry based on the analysis of a panel of 276 
ancestry informative SNPs found that, with increasing 
African ancestry, there is a linear statistically significant 
decrease in the serum level of 25(OH)D [38]. In this study, 
individuals with high African ancestry, (>95%) have 16.5 
ng/mL 25(OH)D whereas people with lower African 
ancestry, (<85%) have 1.2 times more circulating 25(OH)D. 
It is most likely that the evolution of African people has 
selected an adaptive compensatory mechanism to cope with 
a reduced synthesis of previtamin D in the skin due to skin 
hyperpigmentation that reduces the amount of UV-B 
radiation that could reach the epidermis [5, 39]. This 
compensatory mechanism maximizes the synthesis and 
maintenance of optimal serum levels of 1,25(OH)2D in the 
face of low serum 25(OH)D level. The outcome is successful 
maintenance of calcium homeostasis and the health of the 
skeletal system as well as the non-skeletal systems. It is most 
likely that the evolution of this mechanism has involved the 
selection of multiple changes. First, there is the lowering of 
the concentrations of VDBP in the blood to increase the 
bioavailability of 25(OH)D for the synthesis of 1,25(OH)2D 
[22]. Second, there is elevation of the serum PTH to high 
enough levels to perhaps stimulate and maintain high 
amounts of 1--hydrolylase in the kidney for the synthesis of 
adequate amounts of 1,25(OH)2D. Yet, the levels of PTH are 
not too high to causes bone resorption and complications of 
hyperparathyroidism. Third, the 24-hydroxylase catalyzes 
the conversion of 1,25 (OH)2D into the inactive intermediate 
1,24,25(OH)3D [12]. The 24-hydroxylase gene is normally 
expressed at very low level, but its expression is strongly up-
regulated by 1,25(OH)2D [40].
 
It has been demonstrated that 
a unique variant of the vitamin D responsive element 
(VDRE) that weakens the transcriptional activity of the 
promoter of the 24-hydroxylase gene exists in the Black 
population [41]. The consequence of the presence of this 
variant is that the expression of the 24-hydroxylase gene is 
not so robust even in the presence of high concentrations of 
1,25(OH)2D [41]. This change ensures slower rate of 
inactivation of 1,25(OH)2D in Blacks.  
CONCLUSION 
 In summary, it is critical to investigate why Blacks are 
able to maintain a healthy serum 1,25(OH)2D level at all life 
stages despite the fact that they have deficient 25(OH)D 
level (Table 1). Accurate determination of vitamin D status 
in Blacks will be beneficial for the management of their 
overall health since true vitamin D deficiency is correlated 
to, if not the cause of, a long list of negative health 
outcomes, including premature mortality, cancers, 
autoimmune diseases, diabetes, chronic musculoskeletal 
pain, neurological and cognitive disorders, depression, dental 
Table 3. Relationship between various disease risk and low levels of 25(OH)D in caucasians and blacks. 
Diseases 
Risk Associated with Low 25(OH)D Level 
Reference 
Caucasian Blacks 
Stroke Increased risk No apparent association [51] 
CHD Increased risk No apparent association [52] 
PMS No apparent association No apparent association [53] 
CKD Increased fatality No apparent association [54] 
HBP Increased risk No apparent association [55] 
CHD: Coronary Heart Disease; PMS: Premenstrual Syndrome; CKD: Chronic Kidney Disease; HBP: systolic High Blood Pressure. 
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disease and cardiovascular disease [42, 43]. It is therefore of 
utmost importance that future research be focused on better 
understanding of the mechanisms that regulate metabolism 
of vitamin D and maintain a healthy serum 1,25(OH)2D level 
in Blacks.  
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